Granules India announces completion of USFDA inspection of its unit's facility in Virginia

With two observations

Granules India announced that USFDA has completed inspection of the facility of Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of the Company located in Chantilly, Virginia, USA on 25 June 2021 with two (2) minor observations. This is a pre-approval inspection for the products filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time.

Powered by Capital Market - Live News